Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, Uttar Pradesh India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India.
Org Lett. 2023 May 5;25(17):3034-3039. doi: 10.1021/acs.orglett.3c00834. Epub 2023 Apr 24.
A catalyst-controlled divergent synthesis of bridged [3.3.1] bis(indolyl)-oxanes and -[6.7] fused bis(indolyl) oxepanes via diastereoselective desymmetrization of bis(indolyl)-cyclohexadienones is presented for the first time. The reaction is highly atom- and step-economic, furnishing sp-rich functionalized bis(indolyl) derivatives in good to excellent yields with wide substrate scope. The reaction proceeds through Friedel-Crafts alkylation followed by catalyst-controlled selective C-C bond formation/rearrangement. Gram scale synthesis and synthetic utility to generate bis(indolyl) alkaloid-like molecular diversity were also illustrated.
首次通过双(吲哚基)-环己二烯酮的非对映选择性去对称化,实现了桥联[3.3.1]双(吲哚基)-氧杂环戊烷和-[6.7]稠合双(吲哚基)氧杂环庚烷的催化剂控制的发散合成。该反应具有高度的原子经济性和步骤经济性,以良好至优异的收率提供富含 sp 的功能化双(吲哚基)衍生物,底物范围广泛。该反应通过 Friedel-Crafts 烷基化反应进行,随后是催化剂控制的选择性 C-C 键形成/重排。还展示了克级规模合成和合成实用性,以产生双(吲哚基)生物碱样分子多样性。